Literature DB >> 3096328

Ethanol-enhanced transmembrane penetration of arachidonic acid and activation of the 5-lipoxygenase pathway in human leukocytes.

F A Green, H E Claesson.   

Abstract

Enhanced penetration by ethanol of exogenous arachidonic acid into human leukocyte preparations results in the production of large amounts of eicosanoids including 5-, 12- and 15-hydroxyeicosatetraenoic acids as well as the leukotrienes C4 delta 6-trans-leukotriene B4, 12-epi-delta 6-trans-leukotriene B4, leukotriene B4 and 5(S), 12(S)-dihydroxyeicosatetraenoic acid. The production of these compounds is affected by the concentrations of both ethanol and arachidonic acid independently in a complex manner with stimulation at lower concentrations and later relative inhibition. It was shown that the resulting leukotriene B4 exhibited the same specific activity as exogenous arachidonic acid when labelled substrate was used.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096328     DOI: 10.1016/0006-291x(86)90702-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Intracellular cold trapping of exogenous arachidonic acid and activation of the 5-lipoxygenase pathway of human neutrophils.

Authors:  F A Green
Journal:  Inflammation       Date:  1988-02       Impact factor: 4.092

2.  Macrophage function in chronic experimental alcoholism. I. Modulation of surface receptors and phagocytosis.

Authors:  O Bagasra; A Howeedy; A Kajdacsy-Balla
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

3.  Leukotriene production associated with leukocyte membrane destruction: evidence of a terminal signal.

Authors:  F A Green
Journal:  Inflammation       Date:  1988-04       Impact factor: 4.092

4.  The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate.

Authors:  J M Schröder
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.